Gabriella Montes

Popular Topics

Food, Drugs, Healthcare, Life Sciences Intellectual Property

DETAILS

United States

www.goodwinlaw.com

+1 617 5701000

AUTHORS CONTENT

Celltrion Wins Brazilian Federal Tender For Trastuzumab For Fifth Consecutive Year

Worldwide Healthcare

Fresenius Announces Launch Of Subcutaneous Formulation Of TYENNE (Tocilizumab-aazg) In The United States

United States Healthcare

Teva And Alvotech Announce Launch Of SIMLANDI (Adalimumab-ryvk) Injection In The U.S.

United States Healthcare

Accord BioPharma, Inc. Announces FDA Approval Of HERCESSI (Trastuzumab-strf)

United States Healthcare

Fresenius Kabi And Formycon Reach Settlement Agreement For Ustekinumab Biosimilar Candidate In Europe And Canada

Canada Healthcare

FDA Approves XOLAIR To Treat Children And Adults With One Or More Food Allergies

United States Healthcare

Issue 43: PTAB Trial Tracker

United States IP

Fresenius Kabi Launches TYENNE, The First Approved Tocilizumab Biosimilar In The European Union

European Union Healthcare

Coherus To Acquire Surface Oncology

United States Healthcare

Biosimilar Clinical Trial Updates

United States Healthcare

AWARDS

Autumn 2022 Award for Antitrust/Competition Law in United States

Antitrust/Competition Law

Regeneron Files Antitrust Lawsuit Accusing Amgen Of Engaging In A Persistent Exclusionary Campaign To Deny Patients Access To Praluent®

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More